0
Sign In  | Subscribe

Nephrology Collection
 41-60 of 77 Articles
ACP Journal Club |  15 June 2010
Aspirin did not prevent vascular events or mortality in adults with a low ankle–brachial index
PDFPDF
A.C. Felix Burden, MD
Ann Intern Med. 2010;152(12):JC6-11. doi:10.7326/0003-4819-152-12-201006150-02011
ACP Journal Club |  18 May 2010
Good evidence supports use of ACE inhibitors in stable ischemic heart disease; little evidence exists for ARBs
PDFPDF
Vibhuti Singh, MD, MPH
Ann Intern Med. 2010;152(10):JC5-3. doi:10.7326/0003-4819-152-10-201005180-02003
ACP Journal Club |  18 May 2010
Review: Evidence on the effectiveness of sodium bicarbonate regimens to prevent contrast-induced nephropathy is unclear
PDFPDF
Amit X. Garg, MD, PhD
Ann Intern Med. 2010;152(10):JC5-10. doi:10.7326/0003-4819-152-10-201005180-02010
ACP Journal Club |  16 April 2010
Review: Insufficient evidence exists on the benefit of vitamin D in patients with chronic kidney disease not requiring dialysis
PDFPDF
James B. Wetmore, MD
Ann Intern Med. 2010;152(8):JC4-12. doi:10.7326/0003-4819-152-8-201004200-02012
ACP Journal Club |  16 March 2010
Darbepoetin decreased transfusions and fatigue, but increased adverse effects in patients with chronic kidney disease, diabetes, and anemia
PDFPDF
Tejas V. Patel, MD, MPH, FACP, FASN
Ann Intern Med. 2010;152(6):JC3-9. doi:10.7326/0003-4819-152-6-201003160-02009
ACP Journal Club |  16 February 2010
Review: Early treatment of a cardiovascular event with nitrates or ACE inhibitors reduces short-term mortality
PDFPDF
Jason Bradfield, MD; Kalyanam Shivkumar, MD, PhD
Ann Intern Med. 2010;152(4):JC2-3. doi:10.7326/0003-4819-152-4-201002160-02003
ACP Journal Club |  16 February 2010
Higher-intensity continuous renal-replacement therapy did not reduce mortality in critically ill patients with kidney injury
PDFPDF
Chirag R. Parikh, MD, PhD; Justin Belcher, MD
Ann Intern Med. 2010;152(4):JC2-5. doi:10.7326/0003-4819-152-4-201002160-02005
ACP Journal Club |  16 February 2010
Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis
PDFPDF
Daniel G. Hackam, MD, PhD; Amit X. Garg, MD, PhD
Ann Intern Med. 2010;152(4):JC2-6. doi:10.7326/0003-4819-152-4-201002160-02006
ACP Journal Club |  19 January 2010
Review: First-line low-dose thiazides and ACE inhibitors reduce mortality and morbidity in adults with hypertension
PDFPDF
Nirav R. Shah, MD, MPH; Gbenga Ogedegbe, MD, MPH, MS
Ann Intern Med. 2010;152(2):JC1-4. doi:10.7326/0003-4819-152-2-201001190-02004
ACP Journal Club |  17 November 2009
Review: Low BP targets do not reduce mortality or CV events in hypertension
PDFPDF
Finlay A. McAlister, MD
Ann Intern Med. 2009;151(10):JC5-6. doi:10.7326/0003-4819-151-10-200911170-02006
ACP Journal Club |  17 November 2009
Tight BP control reduced left ventricular hypertrophy in nondiabetic patients with hypertension
PDFPDF
Finlay A. McAlister, MD
Ann Intern Med. 2009;151(10):JC5-7. doi:10.7326/0003-4819-151-10-200911170-02007
ACP Journal Club |  15 September 2009
Review: Steroid avoidance or withdrawal does not increase mortality or graft loss in kidney transplant patients
PDFPDF
Mordechai Saeid Nosrati, MD
Ann Intern Med. 2009;151(6):JC3-11. doi:10.7326/0003-4819-151-6-200909150-02011
ACP Journal Club |  18 August 2009
Review: Aldosterone blockade reduces mortality in patients with left ventricular dysfunction
PDFPDF
Peter Liu, MD
Ann Intern Med. 2009;151(4):JC2-9. doi:10.7326/0003-4819-151-4-200908180-02009
ACP Journal Club |  18 August 2009
Review: Combining 2 classes of blood pressure–lowering drugs has an approximately additive effect on systolic blood pressure
PDFPDF
Alena Shantsila, MD; Gregory Y.H. Lip, MD
Ann Intern Med. 2009;151(4):JC2-11. doi:10.7326/0003-4819-151-4-200908180-02011
ACP Journal Club |  21 July 2009
Review: Blood pressure–lowering treatments reduce CV morbidity and mortality in patients receiving dialysis
PDFPDF
John Harnett, MB, BCh
Ann Intern Med. 2009;151(2):JC1-6. doi:10.7326/0003-4819-151-2-200907210-02006
ACP Journal Club |  19 May 2009
What kind of randomized trials do patients and clinicians need?
PDFPDF
Merrick Zwarenstein, MBBCh, MSc; Shaun Treweek, PhD
Ann Intern Med. 2009;150(10):JC5-2. doi:10.7326/0003-4819-150-10-200905190-02002
ACP Journal Club |  19 May 2009
Benazepril plus amlodipine reduced cardiovascular risk more than benazepril plus hydrochlorothiazide
PDFPDF
Simon W. Rabkin, MD
Ann Intern Med. 2009;150(10):JC5-8. doi:10.7326/0003-4819-150-10-200905190-02008
ACP Journal Club |  19 May 2009
Irbesartan did not reduce all-cause death or CV hospitalization in heart failure and preserved ejection fraction
PDFPDF
Justin A. Ezekowitz, MD; Finlay A. McAlister, MD
Ann Intern Med. 2009;150(10):JC5-10. doi:10.7326/0003-4819-150-10-200905190-02010
ACP Journal Club |  17 February 2009
Telmisartan did not reduce a composite of CV death, MI, HF, or stroke in high-risk patients intolerant to ACE inhibitors
PDFPDF
Robin J. Taylor, MD
Ann Intern Med. 2009;150(4):JC2-6. doi:10.7326/0003-4819-150-4-200902170-02006
ACP Journal Club |  17 February 2009
Telmisartan did not prevent recurrent stroke or major cardiovascular events
PDFPDF
Michael A. Sloan, MD, MS
Ann Intern Med. 2009;150(4):JC2-9. doi:10.7326/0003-4819-150-4-200902170-02009
Advertisement

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)